Results 171 to 180 of about 15,628 (311)

A Method to Combine Signals from Spontaneous Reporting Systems and Observational Healthcare Data to Detect Adverse Drug Reactions [PDF]

, 2015

core   +1 more source

<p>Opioids and frequency counts in the US Food and Drug Administration Adverse Event Reporting System (FAERS) database: a quantitative view of the epidemic</p>

, 2019
Michael A. Veronin, Robert P. Schumaker, Rohit Dixit, Harshini Elath   +3 more
openalex   +2 more sources

Top 50 most frequent positive signal adverse events of Ixekizumab at the preferred term (PT) level in males from FAERS data.

Yuzhe Cheng (21417256), Jingyi Ma (3720553), Jun Niu (323242)   +2 more
openalex   +1 more source

Summary of baseline characteristics, disproportionality analysis, onset-time distribution, and additional analyses for SZC adverse events in FAERS.

Yinrui Fang (22169878), Zilun Wu (18696883), Qian Wu (209382), Gangyi Chen (381813)   +3 more
openalex   +1 more source

Venous Thromboembolism and Bleeding with Temozolomide-, Bevacizumab-, and Nitrosourea-Based Therapy in Glioma: A Dual-Database Pharmacovigilance Study. [PDF]

Cancers (Basel)
Hou X, Zhang Y, Liang C, Yao S.
europepmc   +1 more source

Drug-induced liver injury associated with atypical generation antipsychotics from the FDA Adverse Event Reporting System (FAERS) [PDF]

Sidi He, Bin Chen, Chuanwei Li
openalex   +1 more source

SLEEP APNEA ASSOCIATED WITH TICAGRELOR- A PHARMACOVIGILANCE ANALYSIS FROM 2012-2022 FAERS DATABASE

, 2023
Nada Hafez, Omofolarin Babayale, Mohammed Faisaluddin, Asmaa Ahmed   +3 more
openalex   +1 more source

Risk of drug-induced pericardial effusion: a disproportionality analysis of the FAERS database [PDF]

Gaocan Ren, Pingping Huang, Yanqiu Ding, Xiaochang Ma   +3 more
openalex   +1 more source

Gender and age variations in neuropsychiatric adverse events of cetirizine and levocetirizine: a disproportionality analysis of ICSRs from FAERS and EudraVigilance data. [PDF]

Front Pharmacol
Yang T, Wu X, Yi X, Xiang C, Yang Y, Yang C, Zheng X, Han Y, Wang Y.   +8 more
europepmc   +1 more source

Adverse drug reaction assessment of pembrolizumab in cervical cancer treatment: a real-world pharmacovigilance study using the FAERS database [PDF]

Huiping Zhang, Zhuo Zhou, Juan Wang, Shan Wang, Jie Ren, Ming Zhang, Mingyi Yang   +6 more
openalex   +1 more source